The Financial Times reports that AbbVie is close to acquiring biotechnology company Apogee Therapy for approximately $11 billion. The deal is expected to be announced as early as Monday.
2026-06-19
The Financial Times reports that AbbVie is close to acquiring biotechnology company Apogee Therapy for approximately $11 billion. The deal is expected to be announced as early as Monday.